Sep 06, 2023 / 08:20PM GMT
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
All right. Hi, everyone.
Karl Gubitz - argenx SE - CFO
[Good morning, everybody].
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
All right. Hello, everyone. I think we're going to get started. Welcome to the last session of the day before we have drinks on the terrace on the 6th floor. Thank you for being here. It's my pleasure to have Karl Gubitz, CFO of argenx and Beth actually...
Beth DelGiacco - argenx SE - VP and Global Head of Corporate Communications & IR
DelGiacco.
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
DelGiacco.
Karl Gubitz - argenx SE - CFO
(inaudible)
Samantha Lynn Semenkow - Citigroup Inc., Research Division - VP
(inaudible). Thank you for being here with us today. Yes. So maybe, Karl, you want to just kick it off for us.
argenx SE at Citi BioPharma Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot